AN2 Therapeutics Inc (ANTX) — Long-term Investment Intensity
AN2 Therapeutics Inc (ANTX) has a Long-term Investment Intensity of 3.2% as of December 2025. Long-term investments of $2.01 Million represent 3.2% of total assets of $61.95 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See AN2 Therapeutics Inc (ANTX) net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AN2 Therapeutics Inc Long-term Investment Intensity (2021–2025)
This chart shows how AN2 Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 3.2%, reflecting long-term investments of $2.01 Million against total assets of $61.95 Million USD. Also explore AN2 Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for AN2 Therapeutics Inc (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for AN2 Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of AN2 Therapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 3.2% | $2.01 Million | $61.95 Million | ▼ -2.2 pp |
| 2024 | 5.5% | $5.02 Million | $92.09 Million | ▼ -14.1 pp |
| 2023 | 19.6% | $27.19 Million | $138.74 Million | ▲ +16.5 pp |
| 2022 | 3.1% | $3.22 Million | $102.56 Million | ▼ -2.2 pp |
| 2021 | 5.3% | $3.49 Million | $65.32 Million | — |